Johnson & Johnson (JNJ)
Johnson & Johnson (<a href="javascript:void(0)" onclick="quotepop('jnj')">JNJ</a>) is one of the world's largest providers of healthcare products in the consumer, pharmaceutical and medical devices market. It has over 200 operating companies around the world and sells its products in more than 175 countries. <p> J&J has an enormously diverse revenue stream consisting of market leading products in all three of its business segments. Due to a number of products expected to experience declining sales, revenue growth in the next few years will likely slow relative to 2007. Incremental earnings growth will come in the form of improving margins and share buybacks. <p> The company's consistency, product diversity and financial stability make it a very attractive holding in this turbulent market. We rate the stock a Buy based on its attractive valuation and strong company fundamentals. Our price target is $72.
December 30, 2008 | Filed Under Stock Picks
Comments
Leave a Reply